Credit Suisse’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-125,000
Closed -$2.14M 4142
2018
Q4
$2.14M Buy
+125,000
New +$3.03M ﹤0.01% 2193
2018
Q2
Sell
-325,000
Closed -$7.88M 4141
2018
Q1
$7.88M Sell
325,000
-2,929,600
-90% -$58.3M 0.01% 1401
2017
Q4
$49.3M Buy
3,254,600
+2,754,600
+551% +$38.8M 0.04% 427
2017
Q3
$8.21M Buy
+500,000
New +$8.48M 0.01% 1379
2017
Q1
Sell
-30,000
Closed -$445K 4047
2016
Q4
$445K Buy
+30,000
New +$538K ﹤0.01% 3504
2016
Q2
Sell
-114,800
Closed -$3.32M 4343
2016
Q1
$3.32M Sell
114,800
-5,200
-4% -$135K ﹤0.01% 1813
2015
Q4
$3.64M Buy
+120,000
New +$3.94M ﹤0.01% 1835

Other funds holding THC

Credit Suisse's THC Position: Q1 2024 in Review

Credit Suisse reduced its Tenet Healthcare (THC) stake by 0.92% in Q1 2024, selling an estimated $98.6K and leaving 118,317 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #822.

Credit Suisse first reported a position in THC in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.5M in Q2 2015. 460 funds tracked by Wall St. Rank hold THC as of Q1 2024.

  • Credit Suisse held 118,317 shares of Tenet Healthcare worth $12.4M as of Q1 2024.
  • Credit Suisse sold 1,097 Tenet Healthcare shares in Q1 2024, an estimated $98.6K.
  • Tenet Healthcare made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #822 holding.
  • Credit Suisse first reported a position in Tenet Healthcare in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Tenet Healthcare position peaked at $15.5M in Q2 2015.
  • 460 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.